Member Info for technick

also the standard of healthcare and access to vaccines is not the same. With flu you get vaccinated to last years flu, the flu vaccine has not eradicated the disease. COVID has a mortality rate 10x that of influenza, they are not the same type of virus. It's wrong to say that because Spanish flu went away and that we vaccinate against flu, that this current vaccination will be a short term solution. At best we have another 2-3 years of testing, but as I've said before, mutation means selective pressure on genotypes the vaccine doesn't stop... how do you follow those to map new outbreaks? testing. The world is in a pandemic. the world will need constant testing. this is here to stay.

Dream, you're disingenuous, if what you you say is what you believe then you wouldn't post here.

Dream, you're disingenuous, if what you you say is what you believe then you wouldn't post here.

"These findings suggest that the patient was infected by SARS-CoV-2 on two separate occasions by a genetically distinct virus. Thus, previous exposure to SARS-CoV-2 might not guarantee total immunity in all cases. All individuals, whether previously diagnosed with COVID-19 or not, should take identical precautions to avoid infection with SARS-CoV-2. The implications of reinfections could be relevant for vaccine development and application"

for example...

https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30764-7/fulltext

Dream, we all hope the vaccines provide an escape for everyone and stops the deaths that are occurring. However, biology always wins out and as with other viruses I suspect this virus might outsmart us, it's only a matter of time. GDR has already seen a significant drop on 'your' sentiment. I suspect shortly we shall see that testing will outlive the first sets of vaccines.

I believe....

people can bed and ISA their shares into an isa if they have one ahead of the 10th... or even before the divi is paid...

that would be a bad-dream

I agree hulltiger, this is intriguing. There argument before the dividend announcement was that the cash was not reflected in the share price because since the RMS announcements, the share price had dropped from the 45-50p mark. We're now back up there. Why would this then drop 42.75p since as you say 42.75p was not added to the price in the first place.

I think a lot of spooked investors not knowing quite how to value this, time will tell! Roll on the 11th, if this does fall to 12p mark then that will be an oversell I think and I'll be reinvesting that dividend and tripling my holding for the next BRH investment to come good... I doubt that will happen but fingers crossed!

... employees rewarded, keep up the good work

https://in.reuters.com/article/uk-factcheck-vaccine-idUSKBN27W2I7

A better source for you Furion, cell lines are as I suspected used for the production of the viral surrogate to deliver the mRNA into human cells for replication, but the cell lines referred to were not used for manufacture, MRC-5 was used to look at integration of the vector into cells, not the same thing.

There are enough unknowns about the use of these types of vaccines we need to get to the bottom of without additional nonsense, but sometimes you need to nonsense to investigate the depths, but let's filter them out quickly...

Furion, if I have time I’ll fact check. It’s an mRNA and vector, synthesis may be using a cell line...

Grover, don’t give up, it’s what they want, either to reduces the conversation to infantile tit for tat or remove the reasoned debate.

The issue is not LAMP as such, it's the fact that companies like OptiGene have never developed a clinical diagnostic before and had not appreciated some of the nuances around development, particularly with biological samples. Saliva has its particular aspects to take into account. Worse for LFDs because of the various proteins that clog the membranes they use. Genedrive will have encountered these issues before and know what OptiGene don't. Genedrive have years of development experience to bring to the table and will have methodically gone through the issues as part of their development program. Hoping they have their product out soon. The world needs it.

Interesting article with some good quotes from WHO, etc around the length of time the vaccine will need post introduction to work through the system and some of the what if's. Testing here for a longtime, the need for accurate diagnosis is essential and the LFT and OptiGene 'rush jobs' were are learning are not up to the mark. Genedrive has taken the time to make sure they have a gold standard performance. I hope time will show that DB has been ethical, responsible and has maintained integrity in making sure the product is fit for purpose. Genedrive's time to shine will come...

https://www.bbc.co.uk/news/resources/idt-b6360f40-84f9-469b-b6a3-a4568e161c4f

LTH14, yes exactly that. The LFTs are very poor, even with high viral loads. It's not unsurprising, it's been said for a long time here...

https://www.bbc.co.uk/news/health-55188183

Tide turning for Genedrive and its POC qPCR and LAMP test.... doing development properly, let the carp tests hang themselves, time to rise and shine :)

live vaccinations are pointless... they could inject anything

there's a lot more to come, this vaccine was not tested sufficiently and the trials did not monitor to see if volunteers were still infectious but with reduced symptoms, or of those who became infected, was this specific viral genotype. Poor trial, minimal data, but thats what they wanted

Thats assuming you want the 42p, of course with such a high dividend you might be happy with 20p so prepared to pay a 22p premium... profit is a profit so can see this going much higher before the 10/11